Table 1.
Baseline characteristics of patients with and without cancer history.
| No Cancer N = 70 |
Cancer N = 70 |
p-Value | |
|---|---|---|---|
| Age (years); mean ± SD | 69.7 ± 8.7 | 71.3 ± 8.3 | 0.27 |
| Sex, male; n (%) | 39 (55.7) | 39 (55.7) | 1.00 |
| BMI, kg/m2; mean ± SD | 28.0 ± 6.5 | 27.6 ± 5.9 | 0.70 |
| Paroxysmal AF, n (%) | 23 (32.9) | 22 (31.4) | 0.86 |
| Persistent AF, n (%) | 47 (67.1) | 48 (68.6) | 0.86 |
| CHA2DS2-VASC score; median (IQR) | 3 (2;4) | 3 (2;4) | 0.15 |
| Oral anticoagulation with DOAC, n (%) | 55 (78.6) | 56 (80) | 1.0 |
| Oral anticoagulation with vitamin K antagonist, n (%) | 15 (21.4%) | 14 (20) | 1.0 |
| Medical History | |||
| Arterial Hypertension; n (%) | 55 (78.6) | 49 (70) | 0.33 |
| Coronary Artery Disease; n (%) | 10 (14.3) | 12 (17.1) | 0.81 |
| Chronic Renal Insufficiency; n (%) | 17 (24.3) | 22 (31.4) | 0.45 |
| Diabetes mellitus | 7 (10) | 6 (8.6) | 1.00 |
| Implanted cardiac device (%) | 11 (15.7) | 12 (17.1) | 1.00 |
| LVEF (%); mean ± SD | 52.2 ± 8.7 | 50.4 ± 11.6 | 0.30 |
AF = atrial fibrillation; BMI = body mass index; IQR = interquartile range; LVEF = left ventricular ejection fraction; SD = standard deviation.